| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 481 | 2023 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 396 | 2022 |
| Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 D Bryazka, MB Reitsma, MG Griswold, KH Abate, C Abbafati, ... The Lancet 400 (10347), 185-235, 2022 | 227 | 2022 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet infectious diseases 22 (11), 1626-1647, 2022 | 101 | 2022 |
| Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 S Momtazmanesh, SS Moghaddam, SH Ghamari, EM Rad, N Rezaei, ... EClinicalMedicine 59, 2023 | 92 | 2023 |
| Survival in adult inpatients with COVID-19 E Murillo-Zamora, CM Hernandez-Suarez Public health 190, 1-3, 2021 | 60 | 2021 |
| Predictors of laboratory-positive COVID-19 in children and teenagers E Murillo-Zamora, F Aguilar-Sollano, I Delgado-Enciso, ... Public health 189, 153-157, 2020 | 45 | 2020 |
| Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global … YH Shin, J Hwang, R Kwon, SW Lee, MS Kim, ... Allergy 78 (8), 2232-2254, 2023 | 44 | 2023 |
| Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection E Murillo-Zamora, O Mendoza-Cano, I Delgado-Enciso, ... Public Health 193, 113-115, 2021 | 40 | 2021 |
| Performance of the PSI and CURB-65 scoring systems in predicting 30-day mortality in healthcare-associated pneumonia E Murillo-Zamora, A Medina-González, L Zamora-Pérez, ... Medicina Clínica (English Edition) 150 (3), 99-103, 2018 | 40 | 2018 |
| Association between rs2981582 polymorphism in the FGFR2 gene and the risk of breast cancer in Mexican women E Murillo-Zamora, H Moreno-Macías, E Ziv, I Romieu, E Lazcano-Ponce, ... Archives of medical research 44 (6), 459-466, 2013 | 37 | 2013 |
| Persistent arthralgia and related risks factors in laboratory-confirmed cases of Chikungunya virus infection in Mexico E Murillo-Zamora, O Mendoza-Cano, B Trujillo-Hernández, ... Revista Panamericana de Salud Pública 41, e72, 2017 | 31 | 2017 |
| Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 RJ Black, M Cross, LM Haile, GT Culbreth, JD Steinmetz, H Hagins, ... The Lancet Rheumatology 5 (10), e594-e610, 2023 | 30 | 2023 |
| Male gender and kidney illness are associated with an increased risk of severe laboratory-confirmed coronavirus disease E Murillo-Zamora, X Trujillo, M Huerta, M Ríos-Silva, O Mendoza-Cano BMC infectious diseases 20, 1-8, 2020 | 29 | 2020 |
| Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk E Murillo-Zamora, X Trujillo, M Huerta, M Ríos-Silva, F Aguilar-Sollano, ... BMC Infectious Diseases 21, 1-5, 2021 | 27 | 2021 |
| COVID-19 mortality among pregnant women in Mexico: A retrospective cohort study M Ríos-Silva, E Murillo-Zamora, O Mendoza-Cano, X Trujillo, M Huerta Journal of global health 10 (2), 2020 | 27 | 2020 |
| Persistent arthralgia and related risks factors: a cohort study at 12 months from laboratory-confirmed chikungunya infection E Murillo-Zamora, O Mendoza-Cano, B Trujillo-Hernández, ... Archives of medical research 49 (1), 65-73, 2018 | 27 | 2018 |
| Safety and efficacy of a COVID‑19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A … I Delgado‑Enciso, J Paz‑Garcia, CE Barajas‑Saucedo, ... Experimental and Therapeutic Medicine 22 (3), 1-16, 2021 | 25* | 2021 |
| Cost-effectiveness of the strategies to reduce the incidence of dengue in Colima, México O Mendoza-Cano, CM Hernandez-Suarez, X Trujillo, ... International journal of environmental research and public health 14 (8), 890, 2017 | 25 | 2017 |
| The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis GR Aguilar, LR Swetschinski, ND Weaver, KS Ikuta, T Mestrovic, AP Gray, ... The Lancet Regional Health–Americas 25, 2023 | 23 | 2023 |
